Daniel J. Blackman

Showing 1-7 of 7 articles

Interventions for valvular disease

Repositionable percutaneous aortic valve implantation with the LOTUS valve: 30-day and 1-year outcomes in 250 high-risk surgical patients

Meredith I, Dumonteil N, Blackman D, Tchétché D, Walters D, Hildick-Smith D, Manoharan G, Harnek J, Worthley S, Rioufol G, Lefèvre T, Modine T, Van Mieghem N, Feldman T, Allocco D, Dawkins K

September 20, 2017 | 10.4244/EIJ-D-16-01024

Interventions for valvular disease

Insights into the need for permanent pacemaker following implantation of the repositionable LOTUS valve for transcatheter aortic valve replacement in 250 patients: results from the REPRISE II trial with extended cohort

Dumonteil N, Meredith I, Blackman D, Tchétché D, Hildick-Smith D, Spence M, Walters D, Harnek J, Worthley S, Rioufol G, Lefèvre T, Modine T, Van Mieghem N, Houle V, Allocco D, Dawkins K

September 20, 2017 | 10.4244/EIJ-D-16-01025

Coronary interventions

Post-procedural myocardial infarction following surgical aortic valve replacement and transcatheter aortic valve implantation

Dobson L, Musa T, Uddin A, Fairbairn T, Swoboda P, Ripley D, Garg P, Evans B, Malkin C, Blackman D, Plein S, Greenwood J

June 2, 2017 | 10.4244/EIJ-D-16-00558

Interventions for valvular disease

Impact of left ventricular function and transaortic gradient on outcomes from transcatheter aortic valve implantation: data from the UK TAVI Registry

Malkin C, Long W, Baxter P, Gale C, Wendler O, Monaghan M, Thomas M, Ludman P, De Belder M, Cunningham A, Moat N, Blackman D

February 19, 2016 | 10.4244/EIJY14M12_12

Bivalirudin in patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: outcomes in a large real-world population

Shelton R, Eftychiou C, Somers K, Liu A, Burton-Wood N, Anderson M, Makri L, Blaxill J, McLenachan J, Wheatcroft S, Greenwood J, Blackman D

May 21, 2013 | 10.4244/EIJV9I1A17

Complete Versus culprit-Lesion only PRimary PCI Trial (CVLPRIT): a multicentre trial testing management strategies when multivessel disease is detected at the time of primary PCI: rationale and design

Kelly D, McCann G, Blackman D, Curzen N, Dalby M, Greenwood J, Fairbrother K, Shipley L, Kelion A, Heatherington S, Khan J, Nazir S, Alahmar A, Flather M, Swanton H, Schofield P, Gunning M, Hall R, Gershlick A

February 22, 2013 | 10.4244/EIJV8I10A183

Complications of transcatheter aortic valve implantation: avoidance and management

Hildick-Smith D, Redwood S, Mullen M, Thomas M, Kovac J, Brecker S, Trivedi U, Young C, Hutchinson N, Maccarthy P, Prendergast B, De Belder M, Monaghan M, Blackman D, Baumbach A, Manoharan G, Moat N

September 30, 2011 | 10.4244/EIJV7I5A99

Latest news

NEW ISSUE

From measuring stress in bioprosthetic valve leaflets, IABP vs inotropes or data from AIDA and the MeRes-1 trials

(Cover Image: VIC-3D displacement representation)

September 20, 2019

Guidance papers

EHRA/EAPCI Expert Consensus on catheter-based left atrial appendage occlusion (LAAO)

August 31, 2019

JAA

Read this week's JAA's on Transaxillary TAVI and Myocardial Fibrosis in patients undergoing TAVR

September 17, 2019

Guidance papers

Guidelines, consensus & position papers

April 9, 2019

PCR trials

Last Update: Augustus, PARTNER III, NOTION...

(The Trials book is supported by Biotronik)

June 12, 2019

Guidance papers

Clinical use of intracoronary imaging Part 2

Read this consensus to appraise ACS, ambiguous coronary angio findings and interventional decision-making

June 25, 2019

JAA

Lasts weeks's JAA's: SVD following TAVI and much more

September 10, 2019

Daniel J. Blackman

Latest news

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke